Anuh Pharma Limited (ANUHPHR.BO)
INR 171.55
(-1.24%)
INR 171.55
(-1.24%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.45 Billion INR | 10.05% |
| 2022 | 4.04 Billion INR | 16.65% |
| 2021 | 3.47 Billion INR | 4.37% |
| 2020 | 3.32 Billion INR | 1.92% |
| 2019 | 3.26 Billion INR | 35.83% |
| 2018 | 2.4 Billion INR | 14.86% |
| 2017 | 2.09 Billion INR | 10.86% |
| 2016 | 1.88 Billion INR | 3.51% |
| 2015 | 1.82 Billion INR | 8.33% |
| 2014 | 1.68 Billion INR | 3.08% |
| 2013 | 1.63 Billion INR | 19.93% |
| 2012 | 1.36 Billion INR | 14.36% |
| 2011 | 1.19 Billion INR | -3.98% |
| 2010 | 1.23 Billion INR | 12.6% |
| 2009 | 1.1 Billion INR | 31.55% |
| 2008 | 836.92 Million INR | -12.18% |
| 2007 | 953.03 Million INR | 37.9% |
| 2006 | 691.1 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q4 | 4.45 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 3.99 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 4.45 Billion INR | 10.05% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 4.04 Billion INR | 16.65% |
| 2022 Q2 | 3.38 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 4.04 Billion INR | 0.0% |
| 2021 FY | 3.47 Billion INR | 4.37% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 3.36 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 3.47 Billion INR | 0.0% |
| 2020 FY | 3.32 Billion INR | 1.92% |
| 2020 Q4 | 3.33 Billion INR | 0.0% |
| 2020 Q2 | 3.63 Billion INR | 0.0% |
| 2019 Q2 | 2.6 Billion INR | 0.0% |
| 2019 Q4 | 3.26 Billion INR | 0.0% |
| 2019 FY | 3.26 Billion INR | 35.83% |
| 2018 Q2 | 2.44 Billion INR | 0.0% |
| 2018 FY | 2.4 Billion INR | 14.86% |
| 2018 Q4 | 2.4 Billion INR | 0.0% |
| 2017 FY | 2.09 Billion INR | 10.86% |
| 2017 Q4 | 2.09 Billion INR | 0.0% |
| 2017 Q2 | 1.9 Billion INR | 0.0% |
| 2016 Q4 | 1.88 Billion INR | 0.0% |
| 2016 Q2 | 1.86 Billion INR | 0.0% |
| 2016 FY | 1.88 Billion INR | 3.51% |
| 2015 Q4 | 1.82 Billion INR | 0.0% |
| 2015 Q2 | 2.09 Billion INR | 0.0% |
| 2015 FY | 1.82 Billion INR | 8.33% |
| 2014 Q2 | 1.81 Billion INR | 0.0% |
| 2014 FY | 1.68 Billion INR | 3.08% |
| 2014 Q4 | 1.68 Billion INR | 0.0% |
| 2013 Q4 | 1.63 Billion INR | 0.0% |
| 2013 FY | 1.63 Billion INR | 19.93% |
| 2013 Q2 | 1.49 Billion INR | 0.0% |
| 2012 Q4 | 1.36 Billion INR | 0.0% |
| 2012 FY | 1.36 Billion INR | 14.36% |
| 2012 Q2 | 2.93 Billion INR | 0.0% |
| 2011 FY | 1.19 Billion INR | -3.98% |
| 2010 FY | 1.23 Billion INR | 12.6% |
| 2009 FY | 1.1 Billion INR | 31.55% |
| 2008 FY | 836.92 Million INR | -12.18% |
| 2007 FY | 953.03 Million INR | 37.9% |
| 2006 FY | 691.1 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| ANG Lifesciences India Limited | 2.42 Billion INR | -83.833% |
| Add-Shop E-Retail Limited | 1.25 Billion INR | -253.843% |
| Bacil Pharma Limited | 13.26 Million INR | -33508.325% |
| BDH Industries Limited | 934.11 Million INR | -377.116% |
| Beryl Drugs Limited | 174.86 Million INR | -2448.651% |
| Cian Healthcare Limited | 1.61 Billion INR | -176.518% |
| Chemo Pharma Laboratories Limited | 130.15 Million INR | -3324.304% |
| Concord Drugs Limited | 588.06 Million INR | -657.877% |
| Deccan Health Care Limited | 1.08 Billion INR | -312.483% |
| DECIPHER LABS LIMITED | 336.33 Million INR | -1225.123% |
| Gujarat Terce Laboratories Limited | 232.73 Million INR | -1814.968% |
| Gujarat Themis Biosyn Limited | 2.21 Billion INR | -101.562% |
| Hindustan Bio Sciences Limited | 33.74 Million INR | -13108.071% |
| Jenburkt Pharmaceuticals Limited | 1.65 Billion INR | -169.946% |
| Ishita Drugs and Industries Limited | 108.08 Million INR | -4023.345% |
| Kwality Pharmaceuticals Limited | 3.94 Billion INR | -13.057% |
| Panchsheel Organics Limited | 1.59 Billion INR | -180.205% |
| KIMIA BIOSCIENCES LIMITED | 999.66 Million INR | -345.829% |
| Parnax Lab Limited | 1.88 Billion INR | -136.102% |
| Makers Laboratories Limited | 1.61 Billion INR | -176.381% |
| Medi-Caps Limited | 1.27 Billion INR | -250.144% |
| MedPlus Health Services Limited | 30.04 Billion INR | 85.168% |
| Phaarmasia Limited | 314.47 Million INR | -1317.206% |
| Parmax Pharma Limited | 176.12 Million INR | -2430.457% |
| Patidar Buildcon Limited | 94.27 Million INR | -4627.396% |
| Sanjivani Paranteral Limited. | 434.05 Million INR | -926.787% |
| SHAMROCK INDUSTRIAL CO.LTD. | 17.6 Million INR | -25221.289% |
| Trident Lifeline Limited | 870.76 Million INR | -411.828% |
| Tyche Industries Limited | 1.36 Billion INR | -225.553% |
| Vivanza Biosciences Limited | 195.01 Million INR | -2185.374% |
| PRAVEG LIMITED | 3.64 Billion INR | -22.242% |
| Smruthi Organics Limited | 1.18 Billion INR | -277.086% |
| Source Natural Foods and Herbal Supplements Limited | 236.5 Million INR | -1784.426% |
| SUDARSHAN PHARMA INDUSTRIES LI | 2.83 Billion INR | -57.414% |
| Sastasundar Ventures Limited | 11.49 Billion INR | 61.231% |
| Transchem Limited | 763.18 Million INR | -483.978% |
| Trinity League India Limited | 32.38 Million INR | -13661.502% |
| Vikram Thermo (India) Limited | 1.42 Billion INR | -212.374% |
| Vista Pharmaceuticals Limited | 579.79 Million INR | -668.692% |
| Sunil Healthcare Limited | 1.58 Billion INR | -181.186% |
| Syschem (India) Limited | 1.64 Billion INR | -171.71% |
| Zenith Healthcare Limited | 97.41 Million INR | -4475.159% |
| Zenlabs Ethica Limited | 402.58 Million INR | -1007.048% |
| Mercury Laboratories Limited | 679.57 Million INR | -555.823% |
| SHELTER PHARMA LIMITED | 379.14 Million INR | -1075.478% |
| Vasundhara Rasayans Limited | 373.03 Million INR | -1094.756% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1.88 Billion INR | -136.25% |
| Roopa Industries Limited | 647.82 Million INR | -587.968% |
| PANJON LTD. | 173.91 Million INR | -2462.675% |
| Pharmaids Pharmaceuticals Limited | 913.4 Million INR | -387.931% |
| TIAAN CONSUMER LIMITED | 95.12 Million INR | -4585.253% |
| Crestchem Limited | 71.44 Million INR | -6138.347% |
| Emmessar Biotech & Nutrition Limited | 87.42 Million INR | -4997.622% |
| Sandu Pharmaceuticals Limited | 524.14 Million INR | -750.293% |
| Fredun Pharmaceuticals Limited | 3.07 Billion INR | -44.89% |
| Trimurthi Limited | 73.64 Million INR | -5951.401% |
| Shukra Pharmaceuticals Limited | 778.37 Million INR | -472.58% |
| Norris Medicines Limited | 141.87 Million INR | -3041.399% |
| Veerhealth Care Limited | 281.16 Million INR | -1485.102% |
| Lactose (India) Limited | 1 Billion INR | -342.411% |
| OXYGENTA PHARMACEUTICAL LIMITE | 631.92 Million INR | -605.278% |
| Ambalal Sarabhai Enterprises Limited | 2.5 Billion INR | -78.109% |
| Gennex Laboratories Limited | 2.29 Billion INR | -93.786% |
| Denis Chem Lab Limited | 1.09 Billion INR | -307.577% |
| Colinz Laboratories Limited | 113.59 Million INR | -3823.447% |
| Godavari Drugs Limited | 1.34 Billion INR | -230.74% |
| Zenotech Laboratories Limited | 1.06 Billion INR | -319.636% |
| Shree Ganesh Remedies Limited | 1.7 Billion INR | -160.731% |
| Bharat Parenterals Limited | 5.03 Billion INR | 11.54% |
| Coral Laboratories Limited | 2.05 Billion INR | -116.686% |
| Evoq Remedies Limited | 368.61 Million INR | -1109.083% |
| Kerala Ayurveda Limited | 1.4 Billion INR | -216.316% |
| KOBO BIOTECH LIMITED | 713.93 Million INR | -524.259% |
| Natural Capsules Limited | 3.76 Billion INR | -18.367% |
| Auro Laboratories Limited | 852.67 Million INR | -422.682% |